Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis
A legfontosabb adatok
- Ki végzi
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Hol
- Lucknow (India)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2024. jan. 1.
- Tervezett befejezés
- 2025. ápr. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Cryobiopsy with liquid nitrogen
- Endobronchial Forceps Biopsy
- A regiszteradat frissítve
- 2025. március 3.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults who may have sarcoidosis of the lungs and are booked for a routine EBUS-TBNA. EBUS-TBNA is a camera test through the airway that takes samples from lymph nodes. The trial compares two ways of taking airway tissue samples: cryobiopsy (freezing) and forceps.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- Suspected pulmonary sarcoidosis, scheduled for routine EBUS-TBNA
- Korábbi kezelés
- People cannot join if they take steroids now or took them in the last three months. They also cannot join if they take disease-modifying or immune-suppressing drugs.
A részvétel fő kizáró okai
- Age under 18 years
- Diabetes mellitus, kidney failure, long-term liver disease or any other long-term disease
- Steroid use now or in the last three months
- Use of disease-modifying or immune-suppressing drugs
- Final diagnosis that is not sarcoidosis
A regiszter feltételei, szó szerint
Mind a 5 feltétel megnézéseKevesebb
Ki vehet részt
- All patients of suspected pulmonary sarcoidosis scheduled for routine EBUS-TBNA
Ki nem vehet részt
- Patients already on treatment with steroids or h/o steroids intake in last three months or on disease modifying and immunosuppressive drugs
- Patients with co-morbid conditions like Diabetes mellitus, renal failure, chronic liver disease or any other chronic disease
- Patient age less than 18 years
- Final Diagnosis other than sarcoidosis
Helyszínek itt: India
- Sanjay Gandhi Postgraduate Institute of Medical SciencesLucknow, IndiaContact: Alok Nath, MBBS, MD, DMRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Sarcoidosis is a multi-systemic granulomatous disease of unknown cause that is characterized by the formation of non-caseous epithelioid cell granulomas. Sarcoidosis involves the respiratory system in > 90% of cases, usually the hilar and mediastinal nodes, and, less frequently, the lung tissue. Airway involvement, as judged by clinical features, physiologic testing, imaging techniques, bronchoscopy, and airway mucosal biopsy, has been observed in nearly two-thirds of patients with sarcoidosis. Although sarcoidosis involving thoracic lymph nodes and pulmonary parenchyma is familiar to most clinicians, airway involvement is often overlooked. The frequency of airway involvement increases as the parenchymal disease progresses, and\airway involvement is associated with increased morbidity, respiratory symptoms, and mortality. The initial airway abnormality is the inflammation manifested by mucosal edema, erythema, and the formation of granulomas. As the airway disease progresses, the mucosa may demonstrate granularity, nodularity, cobble stoning, and friability. Sarcoid granulomas tend to develop along the bronchovascular bundle or in the vicinity of the airways. Overall quality of the endobronchial biopsy (EBB) will depend on the method by which it is obtained and cryo-EBB will most likely to provide better tissue for the diagnosis in comparison to forceps biopsy which has smaller sample as well as crush artifacts. Therefore, it is hypothesized that cryo-EBB will be better than forceps EBB and combined together it will increase the overall diagnostic yield of the sarcoidosis when combined with lymph node sampling by endobronchial ultrasound guided trans-bronchial needle aspiration (EBUS-TBNA).
A teljes eredeti leírásKevesebb
1. Primary objective: To compare the diagnostic yield of cryo-EBB with forceps biopsy in patients undergoing routine EBUS-TBNA for suspected sarcoidosis. 2. Secondary Objective: To evaluate the overall diagnostic yield of combined endobronchial biopsy and EBUS-TBNA in patients undergoing routine EBUS-TBNA for suspected sarcoidosis.
The relevance and the expected outcome of the proposed study
1. The study will provide insight to obtain an endobronchial biopsy either with cryo probe or forceps 2. The study will also provide information regarding overall increase in diagnostic yield if any when the endobronchial biopsies are combined with EBUS-TBNA.
A vizsgálat 2 csoportja
- Cryo-Endobronchial BiopsyA vizsgált kezelés
Endobronchial biopsy obtained using CRYO-Probe
Kezelés: Cryobiopsy with liquid nitrogen
- Forceps Endobronchial BiopsyMár használt kezelés, összehasonlításként
Endobronchial Biopsy using Standard Bronchoscopic Biopsy Forceps
Kezelés: Endobronchial Forceps Biopsy
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Prospective Randomized Controlled Study Comparing Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients Undergoing Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Suspected Sarcoidosis
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. március 3.